Ligand Pharmaceuticals Incorporated LGND 深 滬
等待開盤 09-08 09:30:00 美东时间
285.60
-4.140
-1.43%
華盛通- 最 高290.00
- 今 開287.41
- 成交量 13.24万股
- 最 低 285.47
- 昨 收 289.74
- 總市值 56.94亿
- 52周最高 326.63
- 市盈率 靜 46.57
- 換手率 0.66%
- 52周最低 161.82
- 委 比 98.39%
- 總股本 1993.56万
- 歷史最高 326.63
- 量 比 0.74
- 振 幅 1.56%
- 歷史最低 -19.8529
- 每 手 1
- 風險率 43.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多If You Invested $100 In Ligand Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today
Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 5 years by 17.28% on an annualized basis producing an average annual return of 28.4%. Currently, Ligand Pharmaceuticals has a market capitalization of $5.72 billion. Buying $100 In LGND: If an investor had bought $100 of ...
09-03 05:00
Ligand to Participate in September Investor Conferences
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) announced that its senior management team will participate in three upcoming investor conferences: the Wells Fargo Healthcare Conference 2026 in Boston on September 8, 2026, the Citi 2026 Biopharma Back to School Conference in New York on September 10, 2026, and the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14, 2026. Management will engage in fireside chats...
08-26 11:00
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Leerink Partners Initiates Coverage On Ligand Pharmaceuticals with Outperform Rating, Announces Price Target of $330
Leerink Partners analyst David Risinger initiates coverage on Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform rating and announces Price Target of $330.
08-15 03:52
Regeneron, Tenet leads top healthcare companies with highest earnings beats
As corporate earnings season progresses, investors are tracking sector performance metrics to gauge underlying healthcare demand and corporate efficiency. For the healthcare sector, spanning critical ...
08-12 18:54
财报速睇 | Ligand Pharmaceuticals Incorporated 2026财年Q2营收0.64亿美元，同比增长33.7%；归母净利润0.49亿美元，同比增长900.8%
华盛资讯8月8日讯，Ligand Pharmaceuticals Incorporated公布2026财年Q2业绩，公司Q2营收0.64亿美元，同比增长33.7%，归母净利润0.49亿美元，同比增长900.8%。
08-08 04:22
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
财报速睇 | Ligand Pharmaceuticals Incorporated 2026财年Q2营收0.64亿美元，同比增长33.7%；归母净利润0.49亿美元，同比增长900.8%
华盛资讯8月6日讯，Ligand Pharmaceuticals Incorporated公布2026财年Q2业绩，公司Q2营收0.64亿美元，同比增长33.7%，归母净利润0.49亿美元，同比增长900.8%。
08-06 22:13
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Oppenheimer Reiterates Outperform on Ligand Pharmaceuticals, Raises Price Target to $326
Oppenheimer analyst Leland Gershell reiterates Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperform and raises the price target from $285 to $326.
08-03 22:23
